Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Dooms C A, Lievens Y N, Vansteenkiste J F. Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer. European Respiratory Journal 2006; 27(5): 895-901 Indexing Status Subject indexing assigned by NLM MeSH Adult; Aged; Antineoplastic Agents /economics /therapeutic use; Carcinoma, Non-Small-Cell Lung /drug therapy /economics; Cisplatin /economics /therapeutic use; Cost-Benefit Analysis; Deoxycytidine /analogs & Female; Humans; Lung Neoplasms /drug therapy /economics; Male; Middle Aged; Vindesine /economics /therapeutic use; derivatives /economics /therapeutic use AccessionNumber 22007000290 Date bibliographic record published 19/02/2007 |